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Single Molecule Microscopy Reveals 
an Increased Hyaluronan Diffusion 
Rate in Synovial Fluid from Knees 
Affected by Osteoarthritis
Hendrik Kohlhof1,*, Sascha Gravius1,*, Sandro Kohl2, Sufian S. Ahmad2, Thomas Randau1, 
Jan Schmolders1, Yorck Rommelspacher1, Max Friedrich1 & Tim P. Kaminski3,†
Osteoarthritis is a common and progressive joint disorder. Despite its widespread, in clinical practice 
only late phases of osteoarthritis that are characterized by severe joint damage are routinely detected. 
Since osteoarthritis cannot be cured but relatively well managed, an early diagnosis and thereby 
early onset of disease management would lower the burden of osteoarthritis. Here we evaluated if 
biophysical parameters of small synovial fluid samples extracted by single molecule microscopy can be 
linked to joint damage. In healthy synovial fluid (ICRS-score < 1) hyaluronan showed a slower diffusion 
(2.2 μm2/s, N = 5) than in samples from patients with joint damage (ICRS-score > 2) (4.5 μm2/s, N = 16). 
More strikingly, the diffusion coefficient of hyaluronan in healthy synovial fluid was on average 30% 
slower than expected by sample viscosity. This effect was diminished or missing in samples from 
patients with joint damage. Since single molecule microscopy needs only microliters of synovial fluid to 
extract the viscosity and the specific diffusion coefficient of hyaluronan this method could be of use as 
diagnostic tool for osteoarthritis.
Osteoarthritis is the most common joint disorder and a major cause of disability1. It is estimated that 10–15% of 
the worldwide population over 60 has some degree of osteoarthritis2.
Osteoarthritis is a progressive multifactorial disease, marked by a breakdown of the articular cartilage by het-
erogeneous causes including abnormal metabolic processes, mechanical injury, joint instability, excessive over-
weight, peripheral neuropathy and ageing3. Lubrication of healthy joints is provided by the interplay of articular 
cartilage at the bone ends in combination with the synovial fluid in between4. This composition provides remark-
ably low friction and low wear5,6. The breakdown of the lubricating properties leads to articular cartilage degra-
dation, osteophyte formation, subchondral sclerosism, meniscal degeneration, bone marrow lesions and synovial 
proliferation3,7. Patients affected by osteoarthritis suffer from pain, limitations of movement and ultimately loss 
of joint function. Currently, there is no cure for osteoarthritis available, except total knee replacement, which still 
leads to loss of joint function8. The symptoms of osteoarthritis can still be managed and progression usually can 
be slowed down through patient education, weight loss, muscle training and hyaluronan injections9.
An obstacle to disease management strategies is the diagnosis of osteoarthritis7,10. Currently osteoarthritis 
diagnosis uses radiographic criteria and clinical symptoms11. However, by that only late stages of osteoarthritis are 
recognized. Therapies that aim to slow down disease progression would benefit from early diagnosis that enables 
an early onset of disease management.
It is projected that in 2050, 130 million people worldwide will suffer from osteoarthritis and 40 million peo-
ple will be disabled by osteoarthritis12. This illustrates the increasing burden of osteoarthritis on communities, 
healthcare systems and the economy.
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Next to finding a cure, strong efforts are made to find biomarkers that allow early diagnosis of osteoarthritis 
and cost effective long-term monitoring of patients. Imaging techniques like quantitative MRI are able to provide 
better diagnosis of early osteoarthritis, but costs and availability are limiting its widespread use7. Therefore, there 
is currently an unmet need for biochemical or biophysical markers that can be measured in blood, urine or syn-
ovial fluid samples11.
It is known that the overall viscosity of synovial fluid decreases in osteoarthritis. Therefore, the viscosity of 
synovial fluid was thought to be a potential biomarker for osteoarthritis. However, the viscosity of synovial fluid 
shows in general a large variance; therefore, its values can be misleading13.
Analyzing the rheological properties at a microscopic scale showed that HA forms a dynamic network in 
synovial fluid14. The existence of a dynamic network in synovial fluid is also supported by studies showing that 
interplay between the major macromolecular molecules of synovial fluid hyaluronan, type II collagen fibrils and 
PRG4 is needed for efficient lubrication15,16. In a previous study, also using single molecule microscopy, a signifi-
cant reduction of HA diffusion speed could be detected in synovial fluid from a patient without a prior history of 
osteoarthritis. In contrast, in synovial fluid from a patient with advanced osteoarthritis there was no reduction of 
HA diffusion speed17. These results suggest a loss of hyaluronan interactions in synovial fluid during osteoarthri-
tis that can be detected via single molecule microscopy.
Single molecule microscopy is a very powerful technique to probe the properties of a single molecular entity 
such as hyaluronan in complex biological environments using selective labeling. Single molecule microscopy 
provides a high spatial and temporal resolution. This method allows extracting even coarse structural information 
of single molecules. By using this method, it could be confirmed that hyaluronan molecules form random coil 
structures in buffer solution17,18.
Here we measured the diffusion coefficient of fluorescent hyaluronan (fl-HA) and compared it to the diffusion 
of fluorescent dextran (fl-dextran), an inert tracer, in human synovial fluid. We analyzed synovial fluid samples of 
patients without joint damage (w/o-JD) and with joint damage (w/-JD).
The diffusion coefficient of spherical objects depends on its hydrodynamic radius, the viscosity of the sur-
rounding medium and temperature. The Stokes-Einstein equation describes the dependency of diffusion coeffi-
cient and these three variables (see M&M) eq. 2). Higher viscosities or larger hydrodynamic radii result in a lower 
diffusion coefficient. Higher temperatures result in a higher diffusion coefficient.
The diffusion coefficient of fl-dextran corresponds to the viscosity of the sample17. For hyaluronan it is known 
that it can undergoes interactions in synovial fluid. The hydrodynamics radius of such conjugates would be larger 
and therefore its diffusion coefficient smaller.
Single molecule microscopy observation of tracer molecules in human synovial fluid samples, as conducted 
here (Fig. 1), would be feasible with standard microscopy equipment. With minimal (microliter) amounts of 
synovial fluid accurate quantitative measurements of diffusion coefficients is possible.
Results
Viscosity of synovial fluid shows large variability. First, the diffusion coefficient of fl-Dextran (Ddex) 
and fl-HA (DHA) was determined in buffer solution (Supplementary Fig. S1). Due to its lower molecular weight 
fl-HA has a higher diffusion coefficient as fl-Dextran in buffer solution.
Fl-Dextran is a commonly used inert probe in single molecule microscopy and its diffusion coefficient (DDex) 
corresponds to the viscosity of the sample. DDex scatter over a wide range for both patient cohorts (Fig. 2). DDex 
of the w/o-JD-group and w/-JD -group show a large overlap and do not differ significantly. Because of their large 
overlap, it is impossible to distinguish the w/-JD -group from the w/o-JD-group based only on DDex respectively 
synovial fluid viscosity.
Three patients showed joint damage (ICRS > 2) during knee arthroscopy. The samples of these patients were 
assigned to the w/-JD-group. Interestingly, DHA and Ddex of these three patients (Fig 2. encircled data points) did 
not differ from the other subjects in the w/-JD-group, which were in need of total knee arthrosplasty.
Slowed hyaluronan diffusion is a characteristic feature of healthy synovial fluid. In contrast to 
DDex, DHA between patients with and without joint damage differs. The diffusion of fl-HA is significantly slower in 
the w/o-JD-group (2.2 μ m2/s) compared to the w/-JD-group (4.6 μ m2/s) (P = 0.01) (Fig. 2).
While average DHA is slower in the w/-JD-group compared to the w/o-JD-group, the distributions of DHA still 
show a great overlap. Therefore, DHA alone is no suitable marker to detect joint damage, either.
While DHA and DDex of both patient cohorts overlap at least to some extent, the w/o-JD-group becomes distin-
guishable from the w/-JD-group by correlating DHA and DDex (Fig. 3).
By just increasing the overall viscosity of the fluid, the ratio of the diffusion coefficients of fl-HA and fl-Dextran 
stay the same (see eq. 2).
DHA and DDex show a linear relationship with a high correlation coefficient in the w/o-JD- and w/-JD-group 
(0.88 & 0.9). The slope of the linear regression in the w/-JD-group (1.3 + /− 0.2) is concurrent with the ratio of 
DHA vs. DDex in buffer (1.3 + /− 0.1) (Fig. 3). In contrast to this, the slope of DHA vs. DDex is reduced to 0.4 + /− 0.1 
in the w/o-JD group.
Discussion
The ratio of DHA and DDex found in our study allows the distinction of patients with and without joint damage. 
Furthermore, patients with advanced osteoarthritis had a similar DHA/DDex ratio as patients who needed total 
knee arthrosplasty. Therefore, we suggest the DHA/DDex ratio could be a suitable marker for osteoarthritis.
A decreased synovial fluid viscosity was linked to pathologic joint conditions of patients suffering from osteo-
arthritis in several studies. Suitability of synovial fluid viscosity as an indicator for osteoarthritis or joint damage 
has been discussed controversial13,19. Its viscosity is influenced by several parameters such as age and physical 
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Figure 1. A single 400 kDa fl-Dextran molecule in synovial fluid imaged over 50 msec. The Brownian 
movements of the molecules are tracked. By analyzing, the distances the molecules move between single frames 
its diffusion coefficient is calculated. Bar 1 μ m.
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activity. Several studies show a large variance of synovial fluid viscosity between different individuals19–21. Our 
results show a large overlap of synovial fluid viscosity between samples of patients with and without joint damage. 
The large overlap shows that synovial fluid viscosity alone is not a reliable marker for osteoarthritis.
More strikingly, we found that in synovial fluid samples fl-HA showed a slower diffusion than expected from 
the sample viscosity. In contrast to that, in samples from patients with joint damage this effect was diminished or 
missing. The diffusion coefficient of fl-HA in samples from patients with joint damage corresponded well to the 
sample viscosity.
As previously described, the well-balanced interaction of the main macromolecular synovial fluid compo-
nents HA, PRG4 and collagen type II fibrils are important for the low coefficient of friction in healthy joints15. 
Progression of osteoarthritis is linked to a higher coefficient of friction. In line with that results our data show 
that HA undergoes intermolecular interactions in healthy joints and these interactions are lost in pathological 
changed joints. The ratio of DHA/DDex presumably allows the discrimination of patients affected by osteoarthritis 
from patients with no hyaline damage. Therefore, we suggest that the DHA/DDex ratio could be used to monitor 
pathological changes in this interplay and thereby the detection of early osteoarthritis.
Furthermore, our data raise the question of whether loss of intermolecular interactions of hyaluronan in syn-
ovial fluid is cause or consequence of osteoarthritis. This will be addressed in future studies.
Figure 2. Hyaluronan diffusion is slowed down in synovial fluid from patients without joint damage but 
not in joints affected by osteoarthritis. The viscosity of synovial fluid sample of patients affected by joint 
damage (w/-JD) tends to be lower, as indicated by the on average higher diffusion coefficient of fl-dextran. The 
overlap between both patient cohorts makes it unfeasible to diagnose joint damage based on synovial fluid-
viscosity. Whereas, the diffusion coefficient of fl-HA is significantly reduced in the w/o-JD-group compared to 
samples collected from patients affected by joint damage. Nevertheless, the HA diffusion coefficients still show 
an overlap between patients with and without joint damage.
Figure 3. (A) Linear regression of DHA vs. DDex shows a selective reduction of HA diffusion coefficient in 
synovial fluid from patients without joint damage (slope = 0.4 + /− 0.1). This reduction is missing synovial fluid 
from patients affected by joint damage (slope 1.3 + /− 0.2). The slope of the w/-JD-group resembles the ratio 
of DHA and DDex found in buffer solution and indicates that in patients with osteoarthritis, HA undergoes no 
or less interactions. The encircled data points represent patients not in need of total knee arthroplasty but with 
an ICRS-score > 2. (B) Analyzing DHA/DDex makes patients with joint damage distinguishable from patients 
without joint damage.
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Single molecule microscopy requires only small sample volumes (10–100 μ l). Furthermore, to its extreme 
sensitivity only picomolar amounts of tracer molecules are needed. Such low concentrations are not changing 
the sample properties and reduce the required amount of tracer molecules dramatically. The samples need no 
further preparation before measurement. The experimental procedure and data analysis can be automated. By 
using state-of-the-art automation equipment, several hundred samples could be analyzed per microscope per 
day. Furthermore, the required image analysis algorithms are already freely available helping to keep the costs of 
this method low.
Thus, single molecule microscopy is a useful method for probing the organization of human synovial fluid and 
shows potential for diagnosis of early osteoarthritis.
Material and Methods
Single Molecule Microscopy. Single-particle imaging experiments were performed using a custom-built 
single molecule microscope based on a Zeiss Axiovert 200 TV equipped with a 100 × NA 1.4 oil immersion 
objective lens (Carl Zeiss Microimaging GmbH, Jena, Germany). Fluorescence was excited at 532 nm by a diode-
pumped solid-state laser (Pluto Pegasus Lasersysteme GmbH, Wallenhorst, Germany). Selective plane illumina-
tion was achieved via HiLo-illumination. Laser illumination was switched on only during image acquisition by 
means of an acousto-optical tunable filter (AA Optoelectronics, Orsay Cedex, France). For single-particle image 
acquisition, we used the iXon DV-860 BI camera (Andor Technology, Belfast, Northern Ireland) in combination 
with a 4× magnifier and 3x binning yielding a pixel size in the object space of 120 nm. Generally, 2500 frames 
were recorded in a single movie, with a frame rate of kacq = 200 Hz. All measurements were performed at 22 °C. 
Since synovial joints are avascular compartments, many of which are located in the periphery of the body, it seems 
reasonable to assume that the temperature in peripheral joints exposed to the ambient can be substantially lower 
than 37 °C. It is assumed that the synovial fluid components can still provide their lubricating properties at 22 °C 
in a physiological relevant manner. The temperature of 22 °C was meant to approximate the conditions in small 
peripheral joints.
Image analysis. Identification of the single-molecule signals and tracking was done with Matlab using a 
self-written single particle-tracking algorithm. Analysis of the trajectory data as described before was done with 
a in house built Matlab program17.
Mathematical analysis of the jump distance distribution. The jump distance distribution of a mole-
cule with diffusion coefficient D is given by
( ) = ( )
− /f x x
Dt
e
2 1
x Dt42
While the diffusion coefficient D of spherical objects is described by the Stokes-Einstein equation
piη
=
( )
D k T
R6 2
b
0
Whereas, kb denotes the Boltzmann constant, T absolute temperature, η the viscosity and R0 the hydrodynamic 
radius.
Statistical Testing. For calculation of all P values, two-tailed Mann-Whitney test was used.
Preparation of fluorescent probes. Fluorescent HA (fl-HA) was prepared from rooster comb HA (aver-
age molecular weight 400 kDa) as described with modifications18. Instead, we used TRITC, due to its superior 
photo stability. Fl-HA was used at a concentration of ≈ 170 pm. As an inert macromolecular tracer fluorescent, 
500-kDa dextran (fl-Dextran) at ≈ 170 pm was used.
Sample collection. The sample collection has been performed by the department of Orthopedic Surgery 
and Traumatology of the University Hospital in Bonn, Germany.
Samples have been taken of patients that underwent surgical procedures such as knee-Arthroscopy and 
Implantation of knee-Arthroplasty. The study was approved by the ethics committee of the University of Bonn, 
Germany, conducted in accordance with the approved guidelines and informed consent was obtained from the 
patients.
Patients who underwent knee-arthroscopy due to damage of the meniscus (medial and lateral were assigned 
to the appropriate group according to their joint status. After implanting the trocar of the arthroscope and before 
starting the lavage, samples of synovial fluid (maximum 5 ml) have been taken.
After inserting the arthroscope, the status of the cartilage has been analyzed. The patients have been struc-
tured in two different groups. If there was no severe cartilage damage (ICRS-score < 1) the patient was assigned 
to Group 1 (w/o-JD N = 5). If there have been severe cartilage damages (ICRS-score > 2) the patient has been 
assigned to Group 2 (w/-JD).
In patients that underwent implantation of a knee arthroplasty due to severe osteoarthritis, synovial fluid has 
been taken before opening joint capsula by using a cannula. These patients were grouped in Group 2(w/-JD total 
N = 16, N = 3 with ICRS-score > 2 and N = 13 with TKA)
Collected samples have been stored for a maximum of 48 h at 4 °C before single molecule measurement.
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